coronary heart atherosclerotic disease
Conditions
Interventions
simvastatin group:the patients were treated by simvastatin 20mg/d
ezetimibe group:the patients were treated by ezetimibe 10mg/d
ezetimibe+simvastatin group:the patients were treated by ezetimibe 10mg/d and simvastatin 20mg/d
Sponsors
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) between the ages of 18-80 years old, male or female; 2) Since November 2015 at the Shanghai Jiaotong University Xinhua Hospital hospitalized due to coronary heart disease; 3) subjects to communicate smoothly with the doctor; 4) voluntary test subjects, and signed informed consent.
Exclusion criteria
Exclusion criteria: 1) older than 80 years of age or less than 18 years old, admission merger trauma, infection system Disease, past or present time admission was found with severe hepatic dysfunction, merge connective tissue disease, evil tumors or clinical and angiographic data incomplete information; 2) The researchers believe that this study can not be completed patients, or patients with poor compliance; 3) the test subjects known drug allergies or intolerance; 4) pregnancy, lactation female patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Trimethylamine-N-oxide;Uric acid;High-sensitivity C-reactive protein;Lipid;Glycated hemoglobin;Left ventricular ejection fraction; | — |
Countries
CHINA
Contacts
Public ContactZhang Yachen
Outcome results
None listed